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Abstract
We test whether the complexity of cardiac interbeat interval time series is
simply a consequence of the wide range of scales characterizing human behav-
ior, especially physical activity, by analyzing data taken from healthy adult
subjects under three conditions with controls: (i) a “constant routine” pro-
tocol where physical activity and postural changes are kept to a minimum,
(ii) sympathetic blockade, and (iii) parasympathetic blockade. We find that
when fluctuations in physical activity and other behavioral modifiers are min-
imized, a remarkable level of complexity of heartbeat dynamics remains, while
for neuroautonomic blockade the multifractal complexity decreases.
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Healthy free-running physiologic systems have complex self-regulating mechanisms which
process inputs with a broad range of characteristics [1], and may generate signals that
have scale-invariant dynamics [2]. Many physiologic time series are extremely “patchy” and
nonstationary, fluctuating in an irregular and complex manner. This observation suggests
that some physiologic signals are sufficiently inhomogeneous that a single fractal exponent
may not be sufficient to characterize them.
Time series of healthy human interbeat intervals belong to a special class of complex
signals that display multifractal properties [3]. Multifractal signals—such as those generated
by binomial multiplicative processes or turbulent fluctuations— can be decomposed into
many subsets characterized by different local Hurst [4] exponents h, which quantify the
local singular behavior and thus relate to the local fractal properties of the time series [4,5].
The statistical properties of the different subsets characterized by the different exponent
values of h are quantified by the function D(h). Here D(ho) is the fractal dimension of
the subset of the original time series characterized by the local Hurst exponent ho [4,5].
For heart rate time series from healthy individuals, the function D(h) is “broad” (implying
multifractality), but “narrow” (implying monofractality) for subjects with heart failure [3],
a life-threatening condition.
An intriguing question, with implications for basic signalling and feedback mechanisms,
is what gives rise to multifractality in healthy human heartbeat dynamics? Two distinct
possibilities can be considered. The first is that the observed multifractality is primarily a
consequence of the response of neuroautonomic control mechanisms to activity-related fractal
stimuli [2]. If this were the case, then in the absence of such correlated inputs the heartbeat
dynamics would not generate such a heterogeneous multifractal output. The second is that
the neuroautonomic control mechanisms —in the presence of even weak external noise—
endogenously generate multifractal dynamics. Here, we present evidence from three new
experiments which supports the latter possibility.
The procedure to calculate the values of h and their corresponding fractal dimensions
has been described elsewhere [3,6–8]. We calculate the experimental τ(q), which is related
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to D(h) through a Legendre transform [4,9,10],
D(h) = q
dτ(q)
dq
− τ(q) . (1)
We first analyze datasets from six healthy, non-smoking male subjects [11] (ages: 21–
30 yr). We obtained two datasets per subject, the first under constant routine conditions,
and the second under usual daily activity conditions [12,13]. Figure 1a displays the average
multifractal spectra τ(q) for the six subjects under both regimens. The nonlinearity of τ(q)
does not appear altered by constant routine conditions. Indeed, our analysis indicates that
major reductions in external stimulation and physical activity do not reduce the multifractal
properties of healthy cardiac dynamics, supporting the hypothesis that the multifractality
in healthy heartbeat dynamics is endogenous to the neuroautonomic regulation of the heart
rate [14,15].
To test the possibility that the multifractality in healthy heartbeat dynamics is related to
neuroautonomic control, we analyze data from six subjects [11] (4 male, 2 female, ages: 21–
34 yr) who were administered a beta-blocking drug [16] which reduces sympathetic control.
We analyzed eight datasets from the six subjects from the the second and/or third day of
beta-blocker administration [13,17]. As a control, we also analyzed eight datasets for the
same subjects but for the second and/or third day of placebo administration [17]. Figure 2a
shows the multifractal spectra for the two groups. The curve for the group corresponding
to the administration of the the beta-blocker drug is more linear than that for the control
group. This result is consistent with decreased multifractality due to the suppression of
sympathetic control (Fig. 2b).
As a further test, we also analyze the multifractal properties of the heartbeat dynamics of
healthy individuals who were administered atropine [18] which suppresses parasympathetic
control of the heartbeat. We analyze six datasets from six different healthy males [11]
(ages: 21–26 yr). As a control, we utilize datasets from subjects in the beta-blockade
experiment after administration of the placebo. Figure 3a shows the multifractal spectra for
the two groups. The curve for the group under parasympathetic blockade is nearly linear
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—indicating a marked loss of multifractality— even more apparent than with sympathetic
blockade (Fig. 3b). These results are consistent with the possibility that multifractality in
healthy heartbeat dynamics may arise, at least in part, from the interplay between the two
branches of the neuroautonomic system.
The major finding of this study is the strong evidence supporting the idea that
(multi)fractality in heartbeat dynamics is related to intrinsic properties of the control mech-
anisms, and is not simply due to changes in external stimulation, degree of physical activity
or other apparent behavioral modifiers—such as postural changes, food intake and sleep-
phase transitions (See Table I). Understanding how the interaction of neuroautonomic, and
possibly other, control mechanisms generates the complex multiscale dynamics of the heart-
beat will be a major challenge to future efforts to model “real-world” signalling mechanisms
[19].
Our results are also of note for a number of other reasons. First, as shown in Figs. 1-3,
the singularity spectrum D(h) during sympathetic blockade has a narrower range of allowed
values of h than the singularity spectra for the control groups. However, the position of the
peak in D(h) during sympathetic blockade is not substantially modified from its position for
the same subjects when given a placebo. This suggests that sympathetic blockade may not
have a major effect on the linear correlations in the dynamics, that is, it does not change
the average Hurst exponent substantially [20].
Second, we find that during parasympathetic blockade there is a marked loss of multifrac-
tality (see Fig. 3b), much as occurs for patients with severe heart failure [3]. Indeed, as with
heart failure, the peak of the singularity spectra is located to the right of the healthy control
group, indicating weaker anticorrelations [2]. This finding is consistent with the hypothesis
that both the monofractality and “weaker” anti-correlations for heart failure dynamics may
be related, at least in part, to impaired parasympathetic control in congestive heart failure
patients, in agreement with recent studies [21].
Third, our finding of the impact of neuroautonomic control on the multifractal properties
of heart rate variability during waking hours raises the question of how transitions during
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sleep might affect these properties. The present study using a constant routine protocol was
not designed to elucidate this intriguing possibility. Recent reports of differences in heartbeat
scaling exponents—related to two-point correlations—between daytime and nighttime hours
[22] and also during different sleep stages [23] support the need for future investigation of
multifractal properties in different physiologic states.
Finally, we note that for many of the systems which generate multifractal signals there
are no mathematical equations describing the dynamics, and even for those for which such
equations exist, their analytical solution is not feasible. Thus, the understanding and model-
ing of the intrinsic control mechanisms for heart rate may offer new opportunities to explore
multifractal dynamics in the natural sciences [24].
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FIG. 1. Constant routine study. The average heart beat interval for constant routine is 0.951
s (0.820 s for controls) and the average standard deviation is 0.117 s (0.129 s for controls). (a)
Multifractal spectra τ(q) for constant routine and control (usual daily activity) protocols (n = 6).
In this and following figures, the error bars indicate the standard error of the group average τ(q).
The two curves have nearly identical curvature but appear to be slightly rotated around a vertical
axis going through q = 0, which suggests that there are no major differences in the multifractal
properties of control and constant routine groups. (b) Singularity spectra D(h) for the two groups.
D(h), which is obtained as the Legendre transform of τ(q), measures the fractal dimension of the
subsets of the signal characterized by local Hurst exponents h. Note that the two curves have
nearly identical widths indicating a similar degree of multifractality. This result is consistent with
the possibility that the activities of daily living do not account for the multifractal complexity of
heart rate dynamics.
−4.0 −2.0 0.0 2.0 4.0
q
−2.0
−1.6
−1.2
−0.8
−0.4
τ(q
)
Metoprolol
Placebo
a
11
0.0 0.1 0.2 0.3
h
0.8
0.9
1.0
D
(h
)
b
FIG. 2. Sympathetic blockade study. The average heart beat interval for beta-blocker intake
is 0.885 s (0.750 s for placebo intake) and the average standard deviation is 0.115 s (0.092 s for
placebo intake). (a) Group average τ(q) for datasets (n = 8) during sympathetic (beta) blockade
with metoprolol [16]. Note that the curve for the beta blocker administration remains above the
placebo curves for all q, indicating a more marked curvature —i.e., nonlinearity— of τ(q) for the
control group. (b) Singularity spectra D(h) for the two groups. The singularity spectrum is ob-
tained by a Legendre transform of the multifractal spectrum. Note that the peaks for the two curves
appear to be at somewhat different positions. However, our analysis indicates that the variation
from group to group and subject to subject is wider for the position of the peak than for its width,
so that no change in peak position can be inferred. Heartbeat dynamics during sympathetic block-
ade display a change in the singularity spectrum, namely decreased multifractality as evidenced
by the narrower distribution D(h). The “weaker” nonlinearity of τ(q) during sympathetic block-
ade indicates less pronounced multifractality, suggesting that suppression of sympathetic control
decreases the multifractal complexity of cardiac dynamics.
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FIG. 3. Parasympathetic blockade study. The average heart beat interval for atropine intake
is 0.703 s and the average standard deviation is 0.078 s. (a) Group average τ(q) for datasets
obtained during parasympathetic (vagal) blockade with atropine (n = 6). Because of the potential
adverse effects associated with very prolonged parasympathetic blockade, these datasets are shorter
than the others, consisting of only about 6,000 interbeat intervals. As a control, we analyze
the first 6,000 data points from the subjects being administered the placebo in the sympathetic
blockade experiments. Our analysis suggests (i) that the dynamics become monofractal under
parasympathetic blockade —note that τ(q) becomes nearly linear— and (ii) that the typical Hurst
exponent increases towards less anti-correlated values as previously observed for severe heart failure
(hHF ≈ 0.25) [2] —note the increase in the slope for q close to zero which is closely related to the
single exponent obtained by a standard (mono)fractal analysis [2]. (b) Singularity spectra D(h) for
the two groups. The singularity spectrum is obtained by a Legendre transform of the multifractal
spectrum. The figure shows that the heart rate dynamics after parasympathetic blockade becomes
nearly monofractal.
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TABLES
TABLE I. Width and peak position for D(h) spectra for the different protocols studied.
Protocol Width Peak
Usual daily activity 0.16 ± 0.04 0.14 ± 0.04
Constant routine 0.18 ± 0.04 0.11 ± 0.04
Placebo 0.20 ± 0.04 0.14 ± 0.04
Sympathetic blockade 0.08 ± 0.04 0.16 ± 0.04
Parasympathetic blockade 0.03 ± 0.03 0.24 ± 0.02
15
